Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Alzheimer’s Disease: Current Treatments and Potential New Agents
Current research focuses on agents that target secretase enzymes to prevent plaque accumulation.
Aripiprazole 1 mg/mL Oral Suspension
This may be suitable for patients who cannot take the solid oral dosage forms or tolerate the ingredients in the commercially available oral solution.
Management of Nonsteroidal Anti-inflammatory Drug-Induced Hypersensitivity Reactions
Hypersensitivity symptoms associated with NSAIDs can range from respiratory and/or cutaneous reactions to angioedema.
Trends in Aspirin Use for Secondary Prevention of ASCVD
According to the CDC’s Behavioral Risk Factor Surveillance System 2013, nearly 71% of adults with atherosclerotic cardiovascular disease use aspirin regularly.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.